Comparing Methylprednisolone And Hyaluronic Acid To Reduce Wisdom Tooth Surgery Complications

Enrolling by invitation · Phase 3

Conditions studied: Wisdom Tooth Removal, Post Operative Complications, Hyaluronic Acid, Methylprednisolone

In brief

The goal of this clinical trial is to assess and compare the effectiveness of methylprednisolone and hyaluronic acid (HA), alone and in combination, in managing post-operative complications following the surgical extraction of impacted mandibular third molars (wisdom teeth). It will also learn about the safety and side effects of these treatments. The main questions it aims to answer are: * How effectively does methylprednisolone reduce post-operative pain, swelling (edema), and limited mouth opening (trismus)? * How effectively does hyaluronic acid reduce post-operative pain, swelling (edema), and limited mouth opening (trismus)? * Is the combination of methylprednisolone and hyaluronic acid more effective than either treatment alone in controlling these post-operative complications? * What complications (e.g., soft tissue issues, infection) do participants experience with each treatment group? Researchers will compare the effects of methylprednisolone (given intravenously before surgery), hyaluronic acid (placed in the tooth socket after extraction), and a combination of both, against a control group that receives standard care (saline irrigation) to see which treatment or combination is most effective. Participants will be medically healthy adults between the ages of 18 and 40 who are undergoing the surgical extraction of a fully impacted mandibular third molar. Participants will be randomly assigned to one of four groups: * Group I (Control): Receive standard care (saline irrigation of the wound). * Group II (Methylprednisolone): Receive a single 125 mg dose of methylprednisolone intravenously one hour before surgery. * Group III (Hyaluronic Acid): Receive 2 ml of hyaluronic acid placed directly into the tooth socket after extraction. * Group IV (Combination): Receive both the pre-operative methylprednisolone injection and the post-extraction hyaluronic acid in the socket. All participants will receive standard post-operative care, including antibiotics and pain medication, and will be followed up periodically to monitor for complications such as soft tissue issues or infection.

Key facts

Study ID

NCT07317596

Run by

Sana'a University

People needed

40

Starts

2024-06-27

Expected to finish

2026-07-15

Last updated by the study team

2026-04-30

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient medically healthy.
• Patient between the ages of 18 and 40
• Patient had impacted mandibular third molar indication for extraction( mesio angler full impaction)
• Patients who were cooperative, motivated, to attend the follow-up

You may not qualify if…

• Pregnant women, children, elderly (>40 years), physically and mentally challenged, terminally and seriously ill.
• Patients who had severe pericoronitis, concomitant carious and/or periodontal disease.
• Patient who had contraindications to the medicines or anesthetics.
• Uncooperative Patients who won't be able to maintain the follow up visits.

Where it is running

• Sana'a University — Sanaa, Yemen

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.